Abstract:Bis(7)-tacrine was evaluated for efficacy on memory retention in mice 17 days of age and 30 days of age. The tests used were a passive-avoidance response test and a measure of spontaneous motor activity. Also, possible drug-induced hepatotoxicity and acute drug toxicity were evaluated. Behavioral studies were performed using a step-through task and an open-field test with a 24-h interval between training and evaluation tests. Bis(7)-tacrine (0.06-20 micromol/kg) was subcutaneously injected 30 min prior to the first session of both test types. During the training session of the step-through task, bis(7)-tacrine treatment reduced (by 46%, P<0.01) the number of avoidable electric shocks (footshocks) only at a high dose of 20 micromol/kg in mice 17 days of age, but dose-dependently decreased the number of footshocks (10-56%, P<0.001) in mice 30 days of age. Bis(7)-tacrine treatment at all doses tested did not produce any detectable changes in retention latency in mice 17 days of age, but the drug significantly prolonged retention latency at low doses (1.25 and 2.50 micromol/kg), and not high doses (5-20 micromol/kg), in mice 30 days of age. In the open-field test, bis(7)-tacrine decreased spontaneous motor activity in the acquisition session only at a high dose of 20 micromol/kg in mice 17 days of age and 30 days of age (by 28 and 45%, respectively), but did not affect spontaneous motor activity in the recall session. Bis(7)-tacrine treatment at a dose of 20 micromol/kg produced a more potent hepatotoxic effect in mice 30 days of age than in mice 17 days of age, (P<0.05), and the drug caused acute toxicity with comparable potencies in mice of both age groups. In conclusion, mice 30 days of age seemed to be more sensitive than mice 17 days of age to bis(7)-tacrine-induced cognitive function enhancement and hepatotoxicity. Bis(7)-tacrine appears to be more potent and more selective as a cognitive function-enhancing agent than tacrine.

Evaluation of Acute Tacrine Treatment on Passive-Avoidance Response, Open-Field Behavior, and Toxicity in 17- and 30-Day-old Mice.

Evaluation of acute bis(7)-tacrine treatment on behavioral functions in 17-day-old and 30-day-old mice, with attention to drug toxicity.

Tacrine Treatment at High Dose Suppresses the Recognition Memory in Juvenile and Adult Mice with Attention to Hepatotoxicity

Tacrine and Bis(7)-Tacrine Attenuate Cycloheximide-Induced Amnesia in Mice, with Attention to Acute Toxicity

Re-evaluation of Tacrine Hepatotoxicity Using Gel Entrapped Hepatocytes.

Region-Specific and Age-Dependent Multitarget Effects of Acetylcholinesterase Inhibitor Tacrine on Comprehensive Neurotransmitter Systems

Tacrine Accelerates Spatial Long-Term Memory Via Improving Impaired Neural Oscillations and Modulating GAD Isomers Including Neuro-Receptors in the Hippocampus of APP/PS1 AD Mice

Attenuation of Scopolamine-Induced Deficits in Navigational Memory Performance in Rats by Bis(7)-Tacrine, a Novel Dimeric AChE Inhibitor.

Kinetic Analysis of the Toxicological Effect of Tacrine (cognex) on Human Retinal Acetylcholinesterase Activity.

The Protective Role of Tacrine and Donepezil in the Retina of Acetylcholinesterase Knockout Mice

A New Tacrine–Melatonin Hybrid Reduces Amyloid Burden and Behavioral Deficits in a Mouse Model of Alzheimer’s Disease

Tacrine(10)-Hupyridone Prevents Post-operative Cognitive Dysfunction Via the Activation of BDNF Pathway and the Inhibition of AChE in Aged Mice

Bis(7)-tacrine, a Novel Acetylcholinesterase Inhibitor, Reverses AF64A-induced Deficits in Navigational Memory in Rats.

Alteration of liver and brain function in mice with hepatic encephalopathy induced by different doses of thioacetamide

Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation

Schisandrin B Protects Against Tacrine- and Bis(7)-tacrine-Induced Hepatotoxicity and Enhances Cognitive Function in Mice

A Single-Center, Randomized, Open-Label, Dose-Escalation Study to Evaluate the Pharmacokinetics of Tacrine Analogue Octahydrogenacridine Succinate Tablets in Healthy Chinese Subjects

Investigation into the in Vivo Effects of Five Novel Tacrine/ferulic Acid and Β-Carboline Derivatives on Scopolamine-Induced Cognitive Impairment in Rats Using Radial Maze Paradigm

Thiamine Deficiency Causes Long-Lasting Neurobehavioral Deficits in Mice

Effects of Bis(7)-Tacrine, A Novel Anti-Alzheimer'S Agent, on Rat Brain Ache

Tacrine Induces Apoptosis Through Lysosome- and Mitochondria-Dependent Pathway in HepG2 Cells.